| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q2 2015 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BERKSHIRE HATHAWAY INC DEL | 8 | Q3 2023 | 74.3% |
| RAPT THERAPEUTICS INC | 8 | Q3 2023 | 3.7% |
| BERKSHIRE HATHAWAY INC DEL | 8 | Q3 2023 | 0.7% |
| VOR BIOPHARMA INC | 7 | Q3 2023 | 9.6% |
| EVELO BIOSCIENCES INC | 6 | Q1 2023 | 2.3% |
| TENAYA THERAPEUTICS INC | 5 | Q3 2023 | 9.2% |
| SURROZEN INC | 5 | Q3 2023 | 7.8% |
| SURROZEN INC | 5 | Q3 2023 | 0.1% |
| SANA BIOTECHNOLOGY INC | 4 | Q3 2023 | 11.4% |
| DISC MEDICINE INC | 4 | Q3 2023 | 7.2% |
View Trustees of Columbia University in the City of New York's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
View Trustees of Columbia University in the City of New York's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.